Back to top

Insider Sale: Director at $THC Sells 3,837 Shares

Christopher S. Lynch, a director at $THC, sold 3,837 shares of the company on 07-27-2026 for an estimated $934,079. We received data on the trade from a recent SEC filing. This was a sale of approximately 28.6% of their shares of this class of stock. Following this trade, they now own 9,568 shares of this class of $THC stock.

$THC Insider Trading Activity

THC Insider Trades

$THC insiders have traded $THC stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.

Here’s a breakdown of recent trading of $THC stock by insiders over the last 6 months:

  • THOMAS W ARNST (EVP, Chief Admin. Officer & GC) has made 0 purchases and 3 sales selling 32,000 shares for an estimated $7,527,737.
  • PAOLA M ARBOUR (EVP, Chief Information Officer) has made 0 purchases and 2 sales selling 17,378 shares for an estimated $4,202,939.
  • R. SCOTT RAMSEY (Principal Accounting Officer) has made 0 purchases and 3 sales selling 8,017 shares for an estimated $1,865,576.
  • JAMES L BIERMAN sold 5,000 shares for an estimated $1,224,800
  • J ROBERT KERREY has made 0 purchases and 5 sales selling 5,638 shares for an estimated $983,920.
  • CHRISTOPHER S. LYNCH sold 3,837 shares for an estimated $934,079
  • NADJA WEST sold 3,000 shares for an estimated $532,050

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$THC Hedge Fund Activity

We have seen 285 institutional investors add shares of $THC stock to their portfolio, and 367 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$THC Revenue

THC Quarterly Revenue

$THC had revenues of $5.6B in Q2 2026. This is an increase of 6.77% from the same period in the prior year.

You can track THC financials on Quiver Quantitative's THC stock page.

You can access data on THC stock through the Quiver Quantitative API.

$THC Congressional Stock Trading

Members of Congress have traded $THC stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $THC stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$THC Price Targets

Multiple analysts have issued price targets for $THC recently. We have seen 13 analysts offer price targets for $THC in the last 6 months, with a median target of $252.0.

Here are some recent targets:

  • Andrew Mok from Barclays set a target price of $240.0 on 07/09/2026
  • Ryan Langston from TD Cowen set a target price of $233.0 on 06/22/2026
  • Michael Ha from Baird set a target price of $210.0 on 05/05/2026
  • Raj Kumar from Stephens & Co. set a target price of $260.0 on 05/04/2026
  • Stephen Baxter from Wells Fargo set a target price of $213.0 on 05/01/2026
  • Matthew Gillmor from Keybanc set a target price of $225.0 on 05/01/2026
  • Jason Cassorla from Guggenheim set a target price of $252.0 on 05/01/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Tenet Healthcare Corporation (THC)